A detailed history of Bank Of America Corp transactions in Pulmonx Corp stock. As of the latest transaction made, Bank Of America Corp holds 35,647 shares of LUNG stock, worth $295,513. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,647
Previous 14,839 140.23%
Holding current value
$295,513
Previous $137,000 64.96%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.77 - $9.82 $120,062 - $204,334
20,808 Added 140.23%
35,647 $226,000
Q1 2024

May 15, 2024

SELL
$8.71 - $14.65 $215,476 - $362,426
-24,739 Reduced 62.51%
14,839 $137,000
Q4 2023

Feb 14, 2024

SELL
$7.89 - $13.14 $208,240 - $346,804
-26,393 Reduced 40.01%
39,578 $504,000
Q2 2023

Aug 14, 2023

SELL
$10.78 - $13.65 $142,339 - $180,234
-13,204 Reduced 16.68%
65,971 $864,000
Q1 2023

May 12, 2023

SELL
$7.49 - $12.54 $17,564 - $29,406
-2,345 Reduced 2.88%
79,175 $885,000
Q4 2022

Feb 10, 2023

BUY
$4.92 - $17.35 $71,522 - $252,216
14,537 Added 21.7%
81,520 $687,000
Q3 2022

Nov 14, 2022

BUY
$15.35 - $23.99 $187,270 - $292,678
12,200 Added 22.27%
66,983 $1.12 Million
Q2 2022

Aug 12, 2022

BUY
$14.0 - $27.95 $41,776 - $83,402
2,984 Added 5.76%
54,783 $806,000
Q1 2022

May 16, 2022

BUY
$21.13 - $35.65 $676,413 - $1.14 Million
32,012 Added 161.78%
51,799 $1.29 Million
Q4 2021

Feb 08, 2022

BUY
$29.72 - $45.1 $72,576 - $110,134
2,442 Added 14.08%
19,787 $634,000
Q3 2021

Nov 15, 2021

SELL
$35.98 - $44.48 $405,998 - $501,912
-11,284 Reduced 39.41%
17,345 $623,000
Q2 2021

Sep 13, 2021

BUY
$37.61 - $48.0 $1.08 Million - $1.37 Million
28,629 New
28,629 $1.26 Million

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $309M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.